Vitiligo: Compendium of clinico-epidemiological features

Indian Journal of Dermatology, Venereology and Leprology

Volumn 73, Issue 3, 2007, Pages 149-156

  Sehgal, Virendra N ^a,c   Srivastava, Govind ^b  

^a Sehgal Nursing Home   (India)

^b Skin Institute and School of Dermatology   (India)

^c NONE   (India)

Author keywords

Clinical connotation; Definition; Epidemiology; Segmental and Nonsegmental vitiligo; Vitiligo

Indexed keywords

AGE DISTRIBUTION; CLINICAL FEATURE; DEPIGMENTATION; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; FAMILY HISTORY; HUMAN; HYPERPIGMENTATION; INCIDENCE; INDIA; LEUKODERMA; MUCOSAL DISEASE; PATHOGENESIS; REVIEW; RURAL AREA; SEX DIFFERENCE; SKIN INFLAMMATION; SYSTEMIC DISEASE; VITILIGO; VOGT KOYANAGI SYNDROME;

EID: 34250312033     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.32708     Document Type: Review

References (131)

1. Najamabadi M. Tarikh-e-Tib-e-Iran. Vol I. Shamsi: Tehran; 1934.
2. Ebbel B. The Papyrus Ebess Copenhagen. Levin and Munksgaard: 1937. p. 45
3. Charaka S, editor. With translation by the Shree Gulabkunverba Society, Volume 4. Chikitsa Sthana: Jamnagar, India; 1949.
4. Sushrut S, Bhishagratna KK. Vol I, Chaukhamba Sanskrit Sansthan: Varanasi; 1963. p. 354.
5. Whitney WD. Atharva-Veda Samhita. Harvard Oriental series. Vol 7, Harvard University Press: Cambridge; 1905.
6. Goldman L, Moraites RS, Kitzmiller KW. White spots in biblical times. A background for the dermatologist for participation in discussions of current revisions of the bible. Arch Dermatol 1966;93:744-53.
7. Bateman TA. Practical synopsis of cutaneous disease. Johnson J: London; 1813.
8. Robert P. Uber die 'Vitiligo'. Dermatologica 1941;4:257-319.
9. Ito M. Vitiligo. Tohoku J Exp Med 1952;5:72-6.
10. Banarjee BN, Pal BK. Leukoderma. Int J Dermatol 1956;2:1-10.
11. Srivastava G. Vitiligo- Introduction Asian Clinic. Dermatol 1994;1:1-5.
12. El Mofty AM. Vitiligo and psoralens. Pergamon Press: Oxford; 1968. p. 1147-95.
13. th ed. Williams and Wilkins: Baltimore, 1992.
14. Fitzpatrick TB. Hypomelanosis. South Med J 1964;57:995-1005.
15. Nair BK. Vitiligo-a retrospect. Int J Dermatol 1978;17:755-7.
16. th ed. Jaypee: New Delhi; 2004. p. 99-101.
17. Behl PN, Bhatia RK. 400 case of vitiligo - A clinico therapeutic analysis. Indian J Dermatol 1971;17:51-4.
18. Punshi SK. Vitiligo. Q Med Rev 1979;30:1-46.
19. el Mofty AM, el Mofty M. Vitiligo - a symptom complex. Int J Dermatol 1980;19:237-44.
20. Klaus S, Lerner AB. Vitiligo. J Am Acad Dermatol 1984;11:997-1000.
21. Scholtz JR. Vitiligo. Arch Dermatol 1985;121:21-2.
22. Dunn JF Jr. Vitiligo. Am Fam Physician 1986;33:137-43.
23. Sharquie KE. Vitiligo. Clin Exp Dermatol 1984;9:117-26.
24. Shwartz RA, Janniger CK. Vitiligo. Cutis 1997;60:239-44.
25. Hann SK, Park YK, Chun WH. Clinical feature of vitiligo. Clin Dermatol 1997;15:891-7.
26. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998;38:647-66.
27. Agarwal G. Vitiligo: An under - estimated problem. Fam Pract 1998;15:519-23.
28. Handa S, Kaur I. Vitiligo - Clinical findings in 1436 patients. J Dermatol Tokyo 1999;26:653-7.
29. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in caucasian probands and their families. Pigment Cell Res 2003;16:208-14.
30. Panja G. Leukoderma. Indian J Vener Dis 1947;13:56-63.
31. Levai M. A study of certain contributory factors in the development of vitiligo in South Indian patients. AMA Arch Derm 1958;78:364-71.
32. Punshi SK, Thakre RD. Skin survey. Maharashtra Med J 1969;16:535-6.
33. Sehgal VN. A clinical evaluation of 202 cases of Vitiligo. Cutis 1974;14:439-45.
34. Koranne RK, Sachdeva KG. Vitiligo. Int J Dermatol 1988;27:676-81.
35. Howitz J, Brodthagen H, Scheartz M, Thomsen K. Prevalence of Vitiligo. Epidemiological survey on the isle of Bornholm, Denmark. Arch Dermatol 1977;113:47-52.
36. Grunnet I, Howitz J, Reymann F, Schwartz M. Vitiligo and pernicious anemia. Arch Dermatol 1970;101:82-5.
37. Dawber RP. Vitiligo in Mature onset diabetes mellitus. Br J Dermatol 1968;80:275-8.
38. Desmons MF. Le vitiligo de Ie'nfant. Bull Soe FR. Dermatol Syphilgr 1974;81:526-7.
39. Perrot H. Vitiligo, Thyreopallisis et autominunization. Lyon. Med 1973;30:325-31.
40. Fornara I. Quoted by Robert P. Uber die vitiligo. Dermatologica 1941;4:241-319.
41. Canizares O. Geographic dermatology: Mexico and Central America. Arch Dermatol 1960;82:870-93.
42. Ruiz-Maldonado R, Tamayo Sanchez L, Velazquez E. Epidemiology of skin diseases in 10,000 patients of pediatric age. Bol Med Hosp Infant Max 1977;34:137-61.
43. Fitzpatrick TB. Phototherapy of vitiligo, in sunlight and man. Normal and abnormal biologic response. In: Pathak MA, editor. University of Tokyo Press: Tokyo; 1974. p. 783-91.
44. Arakawa A. Quoted by Robert P. Uber die Vitiligo, Dermatologica 1941;84:257-319.
45. Khoo OT. Vitiligo. A review and report of treatment of 60 cases in the general hospital, Singapore, from 1954 to 1958. Singapore Med J 1962;3:157-68.
46. Le Poole C, Boissy RE. Vitiligo. Semin Cutan Med Surg 1997;16:3-14.
47. Hann SK, Lee HJ. Segmental vitiligo clinical findings in 208 patients. J Am Acad Dermatol 1996;35:671-4.
48. Zaima H, Koga M. Clinical course of 44 cases of localized type vitiligo. J Dermatol 2002;29:15-9.
49. Jeninger CK. Childhood vitiligo. Br J Dermatol 1993;51:25-8.
50. Halder RM. Childhood Vitiligo. Clin Dermatol 1997;15:899-906.
51. Cho S, Kang KC, Hahm JH. Characteristics of vitiligo in Korean children. Pediatr Dermatol 2000;17:189-93.
52. Handa S, Dogra S. Epidemiology of childhood vitiligo: A study of 625 patients from North India. Pediatr Dermatol 2003;20:207-10.
53. th ed. CBS Publishers: New Delhi; 2003. p. 238-41.
54. Herane MI. Vitiligo and leukoderma in children. Clin Dermatol 2003;21:283-95.
55. Jaigirdar MQ, Alam SM, Maidul AZ. Clinical presentation of vitiligo. Mymensingh Med J 2002;11:79-81.
56. Engel L. What are those white patches in my patient's skin? Dermatol Nurs 2001;13:292-7.
57. Lerner MR, Fitzpatrick TB, Halder RM, Hawk JL. Discussion of a case of vitiligo. Photodermatol Photoimmunol Photomed 1999;15:41-4.
58. Nordlund JJ, Lerner AB. Vitiligo-it is important. Arch Dermatol 1982;118:5-8.
59. Lerner AB. Vitiligo. J Invest Dermatol 1959;32:285-310.
60. Westerhof W. Vitiligo-a window in the darkness. Dermatology 1995;190:181-2.
61. Goudie BM, Wilkieson C, Goudie RB. Skin maps in vitiligo. Scott Med J 1983;28:343-6.
62. Gauthier Y, Cario-Andre M, Lepreux S, Pain C, Taieb A. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. Br J Dermatol 2003;148:95-101.
63. Pegum JS. Vitiligo. Br J Dermatol 1996;134:373.
64. Behl PN. Review of therapeutic measures in the treatment of vitiligo. Indian J Dermtol Venereol 1957;23:17-24.
65. Schallreuter KU, Moore J, Behrens-Williams S, Panske A, Harari M. Rapid initiation of re-pigmentation in vitiligo with dead sea climatotherapy in combination with pseudo catalase. Int J Dermatol 2002;41:482-7.
66. Schallreuter KU. Successful treatment of oxidative stress in vitiligo. Skin Pharmacol Appl Skin Physiol 1999;12:132-8.
67. Ortonne JP. Psoralen therapy in vitiligo. Clin Dermatol 1989;7:120-35.
68. Orecchia G, Perfett L. Phototherapy with topical khellin and sunlight in vitiligo. Dermatology 1992;184:120-3.
69. Arata J, Abe-Matsuura Y. Generalized vitiligo preceded by a generalized figurate erythematosquamous eruption. J Dermatol 1994;21:438-41.
70. Abdel-Naser MB, Ludwig WD, Gollnick H, Orfanos CE. Non segmental vitiligo decrease of the CD45RA+ T-cell subset and evidence for peripheral T-cell activation. Int J Dermatol 1992;31:321-6.
71. Nordlund JJ. The signification of depigmentation. Pigment Cell Res 1992;2:237-41.
72. Al'Abadie MS, Warren MA, Bleehen SS, Gawkrodger DJ. Morphologic observations on the dermal nerves in vitiligo:an ultrastructural study. Int J Dermatol 1995;34:837-40.
73. Fisher AA. Differential diagnosis of idiopathic vitiligo from contact leukoderma. Part II: Leukoderma due to cosmetics and bleaching creams. Cutis 1994;53:232-4.
74. Goudie RB, Spence JC, Mackie R. Vitiligo patterns stimulating autoimmune and rheumatic diseases. Lancet 1979;2:393-5.
75. Wayne DM, Helwig EB. Halo nevi. Cancer 1968;22:69-90.
76. Wee TA. A case report of extensive vitiligo. Hawaii Med J 1997;56:37-40.
77. Drake L, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for vitiligo patients. J Am Acad Dermatol 1996;35:620-6.
78. Hann SK, Chun WH, Park YK. Clinical characteristics of progressive vitiligo. Int J Dermatol 1997;36:353-5.
79. Hautmann G, Panconesi E. Vitiligo: A psychologically influencing disease. Clin Dermatol 1997;15:879-90.
80. Mathias CG, Maibach HI, Conant MA. Perioral leukoderma stimulating vitiligo from use of toothpaste containing cinnamic aldehyde. Arch Dermatol 1980;116:1172-3.
81. O'Sullivan JJ, Stevenson CJ. Screening for occupational vitiligo in workers exposed to hydroquinone monomethyl ether and to para tertiary-amyl-phenol. Br J Ind Med 1981;38:381-3.
82. Hann SK, Kim YS, Yoo JH, Chun YS. Clinical and histological characteristic of trichrome vitiligo. J Am Acad Dermatol 2000;42:589-96.
83. Dupre A, Christol B. Cockade - like vitiligo and linear vitiligo a variant of Fitzpatrick's trichrome vitiligo. Arch Dermatol Res 1978;262:197-203.
84. Fargnoli MC, Bolognia JL. Pentachrome vitiligo. J Am Acad Dermatol 1995;33:853-6.
85. Ivker R, Goldaber M, Buchness MR. Blue vitiligo. J Am Acad Dermatol 1994;30:829-31.
86. Michaelsson G. Vitiligo with raised borders- report of two cases. Acta Derm Venereol 1968;48:158-61.
87. Fisher AA. Differential diagnosis of idiopathic vitiligo: Part III: Occupational leukoderma. Cutis 1994;53:278-80.
88. Koga M, Tango T. Clinical features and course of type A and type B vitiligo. Br J Dermatol 1988;118:223-8.
89. Jarrett A, Szabo G. The pathological varieties of vitiligo and their response to treatment with meladinine. J Dermatol 1956;68:313-26.
90. Sehgal VN, Rege VL, Mascarenhas F, Kharangate VN. Clinical pattern of vitiligo amongst Indians. J Dermatol Tokyo 1976;3:49-53.
91. Ortonne JP, Bahadoran P, Fitzpatrick TB. Hypomelanoses and hypermelanosis. In: Freeberg IM, Eisen AZ, Wolff K, Austen K F, Gold Smith LA, Katz SI, Fitzpatrick TB, editors. Dermatology in general medicine. Mc Graw-Hill: New York; 1999. p. 836-47.
92. Adams BB, Lucky AW. Colocalization of alopecia areata and vitiligo. Pediatr Dermatol 1999;16:364-6.
93. Smyth JR Jr, McNeil M. Alopecia areata and universalis in the Smyth-chicken model for spontaneous autoimmune vitiligo. J Investig Dermatol Symp Proc 1999;4:211-5.
94. Khandpur S, Reddy BS. An association of 20 nails dystrophy with vitiligo. J Dermatol 2001;28:38-42.
95. Lee D, Lazova R, Bolognia JL. A figurate papulosquamous variant of inflammatory vitiligo. Dermatology 2000;200:270-4.
96. Wayte J, Wilkinson JD. Unilateral lichen planus sparing the vitiliginous skin. Br J Dermatol 1995;133:817-8.
97. Anstey A, Marks R. Co-localization of lichen planus and vitiligo. Br J Dermatol 1993;128:103-4.
98. Amato L, Gallerani I, Fuligni A, Mei S, Fabbri P. Dermatitis herpetiformis and vitiligo: Report of a case and review of the literature. J Dermatol 2000;27:462-6.
99. De Sica AB, Wakelin S. Psoriasis vulgaris confined to vitiligo patches and occurring contemporaneously in the same patients. Clin Exp Dermtol 2004;29:434-5.
100. Dervis E, Acbay O, Barut G, Karaoglu A, Ersoy L. Association of vitiligo, morphea and Hashimoto's thyroiditis. Int J Dermatol 2004;43:236-7.
101. Hordinsky M, Ericson M. Autoimmunity: Alopecia areata. J Investig Dermatol Symp Proc 2004;9:73-8.
102. Shin JH, Kim MJ, Cho S, Whang KK, Hahm JH. A case of giant congenital nevocytic nevus with necrotization and on set of vitiligo. J Eur Acad Dermatol Venereol 2002;16:384-6.
103. Midelfart K, Moseng D, Kavli G, Stenvold SE, Volden G. A case of chronic urticaria and vitiligo, associated with thyroiditis, treated with PUVA. Dermatologica 1983;167:39-41.
104. Kang IK, Hann SK. Vitiligo coexistent with nevus dedepigmentosus. J Dermatol Tokyo 1996;23:187-90.
105. Downs AM, Lear JT, Dunnill MG. Polymorphic light eruption limited to areas of vitiligo. Clin Exp Dermatol 1999;24:379-81.
106. IX. Malignant melanoma and vitiligo. J Invest Dermatol 1979;73:491-4.
107. Nordlund JJ, Albert D, Forget B, Lerner AB. Halo nevi and Vogt Koyanagi- Harada syndrome - manifestation of vitiligo. Arch Dermatol 1980;116:690-2.
108. Kumakiri M, Kimura T, Miura Y, Tagawa Y. Vitiligo with an inflammatory erythema in Vogt - Koyanagi- Harada disease: Demonstration of filamentous masses and amyloid deposits. J Cutan Pathol 1982;9:258-66.
109. Barnes L. Vitiligo and Vogt Koyanagi- Harada syndrome. Dermatol Clin 1988;6:229-39.
110. Egli F, Walter R. Images in clinical medicine. Vitiligo and pernicious anemia. N Engl J Med 2004;350:2698.
111. Federman DG, Kravetz JD, Ruser CB, Judson PH, Kirsner RS. Vogt-Koyanagi-Harada syndrome and ulcerative colitis. South Med J 2004;97:169-71.
112. Okada T, Sakamoto T, Ishibashi T, Inomata H. Vitiligo in Vogt-Koyanagi-Harada disease: Immunohistological analysis of inflammatory site. Graefes Arch Clin Exp Ophthalmol 1996;234:359-63.
113. Tsuruta D, Hamada T, Teramae H, Mito H, Ishii M. Inflammatory vitiligo in Vogt-Koyanagi- Harada disease. J Am Acad Dermatol 2001;44:129-31.
114. Fournier GA, Albert DM, Wagoner MD. Choroidal halo nevus occurring in a patient with vitiligo. Surv Opthalmol 1984;28:671-2.
115. Kim YC, Park HJ, Cinn YW. Phakomatosis pigmentovascularis type IIa with generalized vitiligo. Br J Dermatol 2002;147:1028-9.
116. Fisher AA. The role of ocular disturbance in the differentiation of idiopathic vitiligo from contact leukoderma. Cutis 1995;55:61.
117. Feinstein A, Kahana M, Schewach-Millet M, Levy A. Idiopathic calcinosis and vitiligo of the scrotum. J Am Acad Dermatol 1984;11:519-20.
118. Stork J, Nemcova D, Hoza J, Kodetova D. Eosinophilic fasciitis in an adolescent girl with lymphadenopathy and vitiligo-like and linear scleroderma-like changes. A case report. Clin Exp Rheumatol 1996;14:337-41.
119. Montes LF, Pfister R, Elizalde F, Wilborn W. Association of vitiligo with Sjogren's syndrome. Acta Derm Venereol 2003;83:293.
120. Stevens AW, Grossman ME, Barr ML. Orbital myositis, vitiligo and giant cell myocarditis. J Am Acad Dermatol 1996;35:310-2.
121. Stollberger C, Finsterer J, Angel K, Eggl-Tyl E. Unusual cause of leg oedema and plexopathy in a patient with vitiligo. Acta Med Austriaca 2000;27:160-2.
122. Takematsu H, Tomita Y, Sato A, Seiji M. An amelanotic melanoma transformed into melanotic melanoma with development of vitiligo. J Dermatol Tokyo 1981;8:431-8.
123. th ed. Jaypee Brothers: New Delhi; 2004.
124. Kurtev A, Dourmishev AL. Thyroid function and auto-immunity in children and adolescents with vitiligo. J Eur Acad Dermatol Venereol 2004;18:109-11.
125. Sehgal VN, Srivastava G. Vitiligo: Auto-immunity and immune responses. Int J Dermatol 2006;45:583-90.
126. Halder RM, Grimes PE, Cowan CA, Enterline JA, Chakrabarti SG, Kenney JA Jr. Childhood vitiligo. J Am Acad Dermatol 1987;16:948-54.
127. Verma S, Kumar B. Contact leukoderma of the scalp or an unusal variant of vitiligo. J Dermatol 2001;28:554-6.
128. Silvestre JF, Botella R, Ramon R, Guijarro J, Betlloch I, Morell AM. Periumbilical contact vitiligo appearing after allergic contact dermatitis to nickel. Am J Contact Dermatitis 2001;12:43-4.
129. Kossard S, Commens C. Hypopigmented malignant melanoma simulating vitiligo. J Am Acad Dermatol 1990;22:840-2.
130. Sanchez JL, Vazquez M, Sanchez NP. Vitiligolike macules in systemic scleroderma. Arch Dermatol 1983;119:129-33.
131. Saha KC, Arya M, Saha AK. Neurohistological studies in lichen planus and vitiligo. Indian J Dermatol 1979;24:51-5.